| Expression pattern: |
UP |
| Associated gene: |
HuR, CMTM6, PD-L1 |
| Associated microRNA: |
- |
| Biological function: |
Promotes migration and invasion (metastasis-related behaviors) and promotes immune escape of breast cancer cells. |
| Molecular mechanism: |
Binds HuR and promotes its nuclear-to-cytoplasmic translocation, thereby enhancing CMTM6 mRNA stability; increased CMTM6 decreases PD-L1 ubiquitination and inhibits PD-L1 degradation, contributing to immune escape. |
| Biological pathway or process: |
migration (promotes); invasion (promotes); metastasis (promotes); immune regulation (promotes); ubiquitination (inhibits); mRNA stability (promotes) |
| Detected method: |
Q
H
M
|
| Validation methods: |
Microarray; RT-qPCR; Sanger Sequencing; RNase R Treatment; Actinomycin D / DRB Stability Assay; FISH / smFISH; ISH (In Situ Hybridization); Nuclear-Cytoplasmic Fractionation; RNA Pull-Down; RIP (RNA Immunoprecipitation); Transfection; CCK8; Colony Formation Assay; Transwell Assay; Western Blot; IF (Immunofluorescence); Co-IP; Flow Cytometry(Non-apoptosis/cycle); Clinical Sample Validation; Cohort Study; Survival Analysis |
| Clinical significance: |
High hsa_circ_0067842 expression is significantly associated with short disease-free survival (DFS) and overall survival (OS) and serves as an independent prognostic factor for BC patients. |
| Description: |
hsa_circ_0067842 is upregulated in breast cancer and is associated with worse survival. It promotes migration/invasion and immune escape by binding the RBP HuR, facilitating HuR cytoplasmic translocation to stabilize CMTM6 mRNA, which in turn reduces PD-L1 ubiquitination and inhibits PD-L1 degradation. |
| Confidence score: |
0.8818 |